Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Toxicol Sci. 2015 Jun 5;147(1):127–139. doi: 10.1093/toxsci/kfv113

FIG. 7.

FIG. 7

In vivo antibody blockade of TSLP impairs allergic responses in the skin augmented by triclosan. Timeline of treatments to OVA-sensitized mice co-treated with anti-TSLP or isotype control antibodies and dosed daily with triclosan (A). Representative photomicrographs of H&E-stained ear pinnae tissue sections (B) and concentrations of cytokine in ear protein lysates of mice dosed daily with 0% or 3% triclosan and co-treated with anti-TSLP (square) or isotype control (circle) antibodies (n=4–6 mice) (C). Each data point reflects analyses of an ear from an individual mouse (C). Data are representative of two independent studies. Bars represent the mean ± SEM, with statistical significance indicated as P ≤ .05 (*), P ≤ .01 (**), P ≤ .001 (***), and P ≤ .0001 (****).